The SITC 2017 Microlearning: Toxicities Series has been developed with content from abstract and faculty presentations conducted at the Society for Immunotherapy of Cancer 32nd Annual Meeting (SITC 2017). The microlearning series provide a quick, easily accessible format for clinicians and researchers to learn about the latest advances in cancer immunotherapy from experts in the field.
The Toxicities series contains three modules.
Module 1: Antibody-Mediated Neutralization of Soluble MIC Significantly Enhances Response to CTLA4 Blockade and Reduces Therapy-Induced Colitis
Jennifer Wu, PhD - Northwestern University
Module 2: Pharmacological Management of irAEs
Nathan Dahl, PharmD, R.Ph, BCOP - Clovis Oncology
Module 3: Variance from Evidence-Based Management of Immune-Related Adverse Events Among Healthcare Providers: Analysis of an Online Management Decision Tool
Krista Marcello, BA - Clinical Care Options, LLC
These modules have been designed to meet the educational needs of researchers and healthcare professionals involved in cancer research and clinical care.
Course Available Beginning: August 16, 2018
Upon completion of this activity, participants will be able to:
- Understand how immunotherapies can cause unique toxicities.
- Recognize symptoms of immune-related adverse events.
- Describe optimal management of immune-related toxicities.